PCM
SGMO

Princeton Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Princeton Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,350
Closed -$57K – 189
2019
Q3 		$57K Hold
6,350
– – 0.03% 146
2019
Q2 		$68K Hold
6,350
– – 0.03% 135
2019
Q1 		$61K Sell
6,350
-500
-7% -$5.11K 0.03% 138
2018
Q4 		$79K Sell
6,850
-1,000
-13% -$12.4K 0.05% 124
2018
Q3 		$133K Hold
7,850
– – 0.06% 122
2018
Q2 		$111K Hold
7,850
– – 0.05% 128
2018
Q1 		$149K Buy
+7,850
New +$168K 0.07% 104

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Princeton Capital Management's SGMO Position: Q4 2019 in Review

Princeton Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2019, closing a stake of 6,350 shares — an estimated $57K sold.

Princeton Capital Management first reported a position in SGMO in Q1 2018 and held it in 7 quarters. The position peaked at $149K in Q1 2018. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Princeton Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2019 after selling out during the quarter.
  • Princeton Capital Management sold 6,350 SANGAMO THERAPEUTICS INC shares in Q4 2019, an estimated $57K.
  • Princeton Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 7 quarters.
  • Princeton Capital Management's SANGAMO THERAPEUTICS INC position peaked at $149K in Q1 2018.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Princeton Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.